The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Renger John since 2021.
This trader's CIK number is 1830363.
At the time of last reporting, Renger John was the Chief Scientific Officer of Cerevel Therapeutics Holdings, Inc.. (stock ticker symbol CERE).
Also see all insider trading activities at Cerevel Therapeutics Holdings, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CERE | 0 | $0 | 2,161 | $89,776 | 5,020 | $0 |
| 2022 | CERE | 0 | $0 | 306,105 | $10,270,502 | 306,105 | $1,257,817 |
| 2021 | CERE | 0 | $0 | 110,000 | $3,977,154 | 110,000 | $384,999 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-06 | CERE | Option Ex | 5,020 | .00 | 0 |
| 2024-02-07 | CERE | Sale | 2,161 | 41.54 | 89,776 |
| 2022-08-10 | CERE | Sale | 55,000 | 40.65 | 2,235,475 |
| 2022-08-10 | CERE | Option Ex | 55,000 | 6.89 | 378,950 |
| 2022-08-08 | CERE | Sale | 10,000 | 37.75 | 377,500 |
| 2022-08-08 | CERE | Option Ex | 10,000 | 3.50 | 35,000 |
| 2022-08-05 | CERE | Sale | 20,000 | 32.50 | 650,000 |
| 2022-08-05 | CERE | Option Ex | 20,000 | 3.50 | 70,000 |
| 2022-07-20 | CERE | Option Ex | 25,000 | 3.50 | 87,500 |
| 2022-07-20 | CERE | Sale | 25,000 | 30.00 | 750,000 |
| 2022-07-06 | CERE | Sale | 1,105 | 32.50 | 35,912 |
| 2022-07-05 | CERE | Sale | 25,000 | 30.00 | 750,000 |
| 2022-07-06 | CERE | Option Ex | 1,105 | 3.50 | 3,867 |
| 2022-07-05 | CERE | Option Ex | 25,000 | 3.50 | 87,500 |
| 2022-04-13 | CERE | Option Ex | 45,000 | 3.50 | 157,500 |
| 2022-04-13 | CERE | Sale | 45,000 | 34.65 | 1,559,115 |
| 2022-03-16 | CERE | Option Ex | 25,000 | 3.50 | 87,500 |
| 2022-03-16 | CERE | Sale | 25,000 | 30.00 | 750,000 |
| 2022-03-18 | CERE | Option Ex | 20,000 | 3.50 | 70,000 |
| 2022-03-18 | CERE | Sale | 20,000 | 32.50 | 650,000 |
| 2022-03-09 | CERE | Option Ex | 30,000 | 3.50 | 105,000 |
| 2022-03-09 | CERE | Sale | 30,000 | 33.75 | 1,012,500 |
| 2022-03-02 | CERE | Sale | 25,000 | 30.00 | 750,000 |
| 2022-03-02 | CERE | Option Ex | 25,000 | 3.50 | 87,500 |
| 2022-02-09 | CERE | Sale | 25,000 | 30.00 | 750,000 |
| 2022-02-09 | CERE | Option Ex | 25,000 | 3.50 | 87,500 |
| 2021-12-23 | CERE | Sale | 5,873 | 35.01 | 205,584 |
| 2021-12-27 | CERE | Option Ex | 4,127 | 3.50 | 14,444 |
| 2021-12-27 | CERE | Sale | 4,127 | 35.00 | 144,445 |
| 2021-12-23 | CERE | Option Ex | 5,873 | 3.50 | 20,555 |
| 2021-12-21 | CERE | Sale | 7,300 | 32.50 | 237,250 |
| 2021-12-21 | CERE | Option Ex | 7,300 | 3.50 | 25,550 |
| 2021-12-15 | CERE | Option Ex | 25,000 | 3.50 | 87,500 |
| 2021-12-16 | CERE | Option Ex | 5,578 | 3.50 | 19,523 |
| 2021-12-15 | CERE | Sale | 25,000 | 30.02 | 750,450 |
| 2021-12-17 | CERE | Option Ex | 7,122 | 3.50 | 24,927 |
| 2021-12-16 | CERE | Sale | 5,578 | 32.50 | 181,285 |
| 2021-12-17 | CERE | Sale | 7,122 | 32.50 | 231,465 |
| 2021-11-10 | CERE | Option Ex | 55,000 | 3.50 | 192,500 |
| 2021-11-10 | CERE | Sale | 55,000 | 40.48 | 2,226,675 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Renger John (Chief Scientific Officer of Cerevel Therapeutics Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.